PB
| |
Paradigm Biocapital Advisors LP13F | |
Paradigm Biocapital Advisors LP | |
Last update 2025-05-15 | 28 Stocks (5 new) |
Value $2.18 Bil | Turnover 14 % |
Paradigm Biocapital Advisors L... Top Holdings of 2025-03-31
View Full List
Ticker | | Company | Shares | Value ($1000) | Shares Change % | Weighting % | Trade Impact % | % of Shares outstanding | 3M Change % | YTD Change % | Market Cap $Mil | Industry |
---|---|---|---|---|---|---|---|---|---|---|---|---|
NUVL | Nuvalent Inc | 5,269,433 | 373,708.2 | -1.75% | 17.120 | -0.26% | 7.340 | +10.07% | -0.13% | 5,614.0 | Biotechnology | |
ACLX | Arcellx Inc | 4,492,032 | 294,677.3 | +2.75% | 13.500 | +0.36% | 8.150 | +4.01% | -15.06% | 3,589.7 | Biotechnology | |
RVMD | Revolution Medicines Inc | 6,178,111 | 218,458.0 | -5.72% | 10.010 | -0.57% | 3.320 | +5.84% | -7.22% | 7,558.7 | Biotechnology | |
ONC | BeiGene Ltd | 666,024 | 181,271.8 | +8.12% | 8.300 | +0.62% | 0.620 | +2.52% | +36.28% | 28,647.7 | Biotechnology | |
MRUS | Merus NV | 3,369,699 | 141,830.6 | +99.40% | 6.500 | +3.24% | 4.870 | +37.28% | +48.44% | 4,320.3 | Biotechnology | |
TARS | Tarsus Pharmaceuticals Inc | 2,610,197 | 134,085.8 | +3.09% | 6.140 | +0.18% | 6.210 | +2.79% | -20.70% | 1,844.8 | Biotechnology | |
EWTX | Edgewise Therapeutics Inc | 4,394,556 | 96,680.2 | -2.21% | 4.430 | -0.09% | 4.180 | -41.87% | -44.42% | 1,561.2 | Biotechnology | |
JANX | Janux Therapeutics Inc | 3,329,909 | 89,907.5 | -5.29% | 4.120 | -0.35% | 5.630 | -20.11% | -52.50% | 1,504.8 | Biotechnology | |
CRNX | Crinetics Pharmaceuticals Inc | 1,946,168 | 65,274.5 | +1.85% | 2.990 | +0.05% | 2.080 | -5.98% | -37.22% | 3,007.1 | Biotechnology | |
PCVX | Vaxcyte Inc | 1,696,481 | 64,059.1 | +19.24% | 2.930 | +0.47% | 1.320 | -51.94% | -57.67% | 4,470.0 | Biotechnology |
Paradigm Biocapital Advisors LP's Historical Top Holdings Breakdowns
Paradigm Biocapital Advisors LP's Top Stock Picks
View Full List
Ticker | | Company | Date | Action | Impact % | Price Range | Price | Price Change from Avrg% | Comment | Current Shares | Share Change |
---|---|---|---|---|---|---|---|---|---|---|---|
ARGX | argenx SE | 2025-03-31 | Reduce | -9.02% | 571 ($631.12) 671.75 | $576.61 | -8.64% | Reduce -87.6% | 59,679 | -421,626 | |
MRUS | Merus NV | 2025-03-31 | Add | +3.24% | 39.01 ($43.61) 49.16 | $62.42 | 43.13% | Add 99.4% | 3,369,699 | 1,679,777 | |
MLTX | MoonLake Immunotherapeutics | 2025-03-31 | Reduce | -2.16% | 36.75 ($43.09) 53.57 | $48.55 | 12.67% | Reduce -64.6% | 627,423 | -1,144,788 | |
VERA | Vera Therapeutics Inc | 2025-03-31 | Sold Out | -2.11% | 24.02 ($32.13) 43.22 | $30.91 | -3.80% | Sold Out | 0 | -1,437,339 | |
CYTK | Cytokinetics Inc | 2025-03-31 | New Buy | +1.58% | 40.19 ($45.96) 51.12 | $32.00 | -30.37% | New holding | 858,664 | 858,664 | |
INSM | Insmed Inc | 2025-03-31 | New Buy | +1.58% | 65.25 ($76.49) 83.83 | $73.08 | -4.46% | New holding | 451,359 | 451,359 | |
MTSR | Metsera Inc | 2025-03-31 | New Buy | +1.49% | 24.26 ($28.34) 32.08 | $29.35 | 3.56% | New holding | 1,191,462 | 1,191,462 | |
PLRX | Pliant Therapeutics Inc | 2025-03-31 | Sold Out | -1.46% | 1.35 ($6.07) 13.53 | $1.60 | -73.64% | Sold Out | 0 | -3,197,050 | |
COGT | Cogent Biosciences Inc | 2025-03-31 | Add | +1.11% | 5.99 ($7.84) 9.66 | $5.79 | -26.15% | Add 82.28% | 8,963,655 | 4,046,243 | |
ARQT | Arcutis Biotherapeutics Inc | 2025-03-31 | New Buy | +1.05% | 11.4 ($14.09) 17.29 | $13.27 | -5.82% | New holding | 1,465,334 | 1,465,334 |
Paradigm Biocapital Advisors LP Total Holding History ($B)
Paradigm Biocapital Advisors LP's Asset Allocation
Paradigm Biocapital Advisors LP Past Portfolios
Portfolio Date | Number of Stocks | New Stocks | Total Value ($Mil) | Q/Q Turnover |
---|---|---|---|---|
Top Ranked Articles
- 1
Paradigm Biocapital Advisors LP's Hypothetical Growth since 2025-03-31
Paradigm Biocapital Advisors LP's Yearly Returns
Year | Portfolio % | % | Excess Gain % |
---|
Paradigm Biocapital Advisors LP's Holdings Heat Map
Size field:
Paradigm Biocapital Advisors LP's Holdings Bubble Chart
Paradigm Biocapital Advisors LP News
- 1